Stereotaxis Revenue and Competitors
Estimated Revenue & Valuation
- Stereotaxis's estimated annual revenue is currently $35M per year.
- Stereotaxis's estimated revenue per employee is $184,211
- Stereotaxis's total funding is $80M.
Employee Data
- Stereotaxis has 190 Employees.
- Stereotaxis grew their employee count by 0% last year.
Stereotaxis Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $24.6M | 98 | -4% | N/A | N/A |
#2 | $36.6M | 146 | 2% | N/A | N/A |
#3 | $8.5M | 34 | 3% | N/A | N/A |
#4 | $2.8M | 11 | 10% | N/A | N/A |
#5 | $75M | 142 | -6% | N/A | N/A |
#6 | $17.8M | 71 | 13% | N/A | N/A |
#7 | $35M | 190 | 0% | $80M | N/A |
#8 | $12.6M | 50 | 9% | N/A | N/A |
#9 | $28.1M | 112 | -20% | N/A | N/A |
#10 | $9.8M | 39 | 3% | N/A | N/A |
What Is Stereotaxis?
Stereotaxis, Inc. is developing solutions in computer integrated interventional medicine. The Company's core technology is a proprietary interventional workstation and toolkit of related disposables (collectively referred to as the "Stereotaxis System") designed to be capable of remotely directing and digitally controlling catheter based therapeutic and diagnostic devices along complex trajectories within the body, providing potential important solutions to major interventional challenges. Stereotaxis received 510(k) clearance from the FDA for its Telstar General Navigation system and bi-plane flat plate digital imaging platform as well as its EP mapping catheter in May 2002.
keywords:Biotechnology
$80M
Total Funding
190
Number of Employees
$35M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Stereotaxis's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Senior Regulatory Affairs Specialist | Reveal Email/Phone |
2 | Senior Manager Sales Operations | Reveal Email/Phone |
3 | Director, Clinical Training | Reveal Email/Phone |
4 | Manager, Accounting Operations | Reveal Email/Phone |
5 | Senior Sales Director | Reveal Email/Phone |
6 | Director Clinical Engineering and New Concepts | Reveal Email/Phone |
7 | Director IT | Reveal Email/Phone |
8 | Director, Human Resources | Reveal Email/Phone |
9 | Director, Talent Acquisition (Global) | Reveal Email/Phone |
10 | Excecutive Assistant to CEO, VP, General Counsel | Reveal Email/Phone |
Stereotaxis News
Stereotaxis (NYSEAMERICAN:STXS) Stock Rating Lowered by Zacks Investment Research. Posted by admin on Apr 21st, 2022.
Stereotaxis (NYSEAMERICAN:STXS) Lifted to Hold at Zacks Investment Research. Posted by admin on Apr 15th, 2022.
a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release...
ST. LOUIS and SHANGHAI, China, Aug. 30, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS) and Shanghai Microport EP Medtech Co., Ltd. (“MicroPort EP”) today announced a broad collaboration to advance technology innovation and commercial adoption of robotics in electrophysiology in China. The ag ...
Stereotaxis Inc. (NSDQ:STXS) reported strong fourth-quarter and year-end sales, helping the company narrow losses nearly 38 percent in 2009. The St. Louis, Mo.-based cardiology instrument control system maker reported a net loss of $6.7 million on $14 million in sales during the three months en ...
Other Companies in St. Louis
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | N/A | 190 | 7% | N/A |
#2 | N/A | 190 | 31% | N/A |
#3 | $46.9M | 190 | 7% | N/A |
#4 | $37.6M | 190 | 3% | N/A |
#5 | $21.1M | 192 | 9% | N/A |